The effect of arterial oxygen tension on antipyrine half-time in plasma
- PMID: 1269198
The effect of arterial oxygen tension on antipyrine half-time in plasma
Abstract
Hospital patients with depressed arterial oxygen tensions (PaO2) from pulmonary disease were given antipyrine orally or intravenously. The half-time (t1/2) of disappearance from plasma was measured. Other patients with normal PaO2 measurements were treated similarly. Patients whose PaO2 was 55 or below had longer t1/2 times than those of patients with a PaO2 above 55. This observation parallels that made previously in rats.
Similar articles
-
Plasma pharmacokinetics of adriamycin and antipyrine and its relation to the therapeutic and toxic effects.Int J Clin Pharmacol Ther Toxicol. 1985 Apr;23 Suppl 1:S79-88. Int J Clin Pharmacol Ther Toxicol. 1985. PMID: 3842695
-
[The relationship between antipyrine kinetics and the change in the seromucoid content of rat plasma under the influence of the immunomodulator levamisole].Farmakol Toksikol. 1990 Sep-Oct;53(5):55-8. Farmakol Toksikol. 1990. PMID: 2253753 Russian.
-
Comparative investigation of antipyrine half-life and induction of cytochrome P-450 dependent monooxygenases in rats treated with phenylurea herbicides.In Vivo. 1987 May-Jun;1(3):185-7. In Vivo. 1987. PMID: 2979785
-
Effect of age on antipyrine metabolism in patients with gastric cancer.J Natl Cancer Inst. 1980 Nov;65(5):897-900. J Natl Cancer Inst. 1980. PMID: 6933259
-
Serum gamma-glutamyl transpeptidase, D-glucaric acid excretion and plasma half-life of antipyrine in newborns with severe jaundice of unknown etiology and due to glucose-6-phosphate dehydrogenase deficiency in Greece.Helv Paediatr Acta. 1981;36(2):149-58. Helv Paediatr Acta. 1981. PMID: 6114077
Cited by
-
The effect of respiratory disorders on clinical pharmacokinetic variables.Clin Pharmacokinet. 1990 Dec;19(6):462-90. doi: 10.2165/00003088-199019060-00004. Clin Pharmacokinet. 1990. PMID: 2292169 Review.
-
Drugs and brain death.Drug Saf. 1996 Mar;14(3):171-80. doi: 10.2165/00002018-199614030-00004. Drug Saf. 1996. PMID: 8934579 Review.
-
Metabolism of procainamide in patients with chronic heart failure, chronic respiratory failure and chronic renal failure.Eur J Clin Pharmacol. 1978 Nov 9;14(1):21-7. doi: 10.1007/BF00560254. Eur J Clin Pharmacol. 1978. PMID: 729603
-
Chronic pulmonary disease and antipyrine disposition.Br J Clin Pharmacol. 1978 Mar;5(3):275-7. doi: 10.1111/j.1365-2125.1978.tb01641.x. Br J Clin Pharmacol. 1978. PMID: 656277 Free PMC article. No abstract available.
-
Intermittent Hypoxia Inhibits Hepatic CYP1a2 Expression and Delays Aminophylline Metabolism.Evid Based Complement Alternat Med. 2022 Apr 29;2022:2782702. doi: 10.1155/2022/2782702. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35529917 Free PMC article.